Karniadakis, I.; Mazonakis, N.; Tsioutis, C.; Papadakis, M.; Markaki, I.; Spernovasilis, N.
Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence. Infect. Dis. Rep. 2023, 15, 662-678.
https://doi.org/10.3390/idr15060061
AMA Style
Karniadakis I, Mazonakis N, Tsioutis C, Papadakis M, Markaki I, Spernovasilis N.
Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence. Infectious Disease Reports. 2023; 15(6):662-678.
https://doi.org/10.3390/idr15060061
Chicago/Turabian Style
Karniadakis, Ioannis, Nikolaos Mazonakis, Constantinos Tsioutis, Michail Papadakis, Ioulia Markaki, and Nikolaos Spernovasilis.
2023. "Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence" Infectious Disease Reports 15, no. 6: 662-678.
https://doi.org/10.3390/idr15060061
APA Style
Karniadakis, I., Mazonakis, N., Tsioutis, C., Papadakis, M., Markaki, I., & Spernovasilis, N.
(2023). Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence. Infectious Disease Reports, 15(6), 662-678.
https://doi.org/10.3390/idr15060061
